Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD000850)
Article History
First Online: 22 May 2026
Competing interests
: S.R.P. has served as a consultant for Moderna, Merck, Pfizer, Dynavax and Kamada, and led sponsored research programmes with Moderna, Pfizer, Dynavax and Kamada on CMV vaccines. I.D.E. is an unpaid champion and advocate for the United Nations Foundation’s Shot@Life initiative, which advocates for policies related to this paper. C.S. declares no competing interests.